|
|||||
|
|
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi‐institution analysis from the U.S. extrahepatic biliary malignancy consortium |
|
| Authors: | Bradley A. Krasnick MD Linda X. Jin MD Jesse T. Davidson MD IV Dominic E. Sanford MD MPHS Cecilia G. Ethun MD Timothy M. Pawlik MD MPH PhD George A. Poultsides MD Thuy Tran MD Kamran Idrees MD William G. Hawkins MD William C. Chapman MD Maria B.M. Doyle MD Sharon M. Weber MD Steven M. Strasberg MD Ahmed Salem MD Robert C.G. Martin MD PhD Chelsea A. Isom MD Charles Scoggins MD MBA Carl R. Schmidt MD Perry Shen MD Eliza Beal MD Ioannis Hatzaras MD MPH Rivfka Shenoy MD Shishir K. Maithel MD Ryan C. Fields MD |
| Affiliation: | 1. Department of Surgery, Washington University School of Medicine, St Louis, Missouri;2. Winship Cancer Institute, Emory University, Atlanta, Georgia;3. The Ohio State University Comprehensive Cancer Center, Columbus, Ohio;4. Stanford University Medical Center, Palo Alto, California;5. Vanderbilt University Medical Center, Nashville, Tennessee;6. University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin;7. University of Louisville, Louisville, Kentucky;8. Wake Forest University, Winston‐Salem, North Carolina;9. New York University, New York, New York |
| Abstract: | |
| Keywords: | adjuvant therapy biliary cancer chemotherapy hilar cholangiocarcinoma survival |